European Journal of Pediatrics

, Volume 169, Issue 12, pp 1439–1444 | Cite as

EPONYM

Sweet syndrome
Review

Abstract

Sweet syndrome, also referred to as acute febrile neutrophilic dermatosis, is characterized by tender, red inflammatory nodules or papules that occur in association with infection, malignancy, connective tissue disease, or following exposure to certain drugs. Although drug-induced Sweet syndrome is rare, granulocyte colony-stimulating factor, all-trans-retinoic acid, and miscellaneous drugs have been implicated in causing this disorder in adults. In pediatric patients, granulocyte colony-stimulating factor, all-trans-retinoic acid, trimethoprim-sulfamethoxazole, and azathioprine have been implicated as potential causes of drug-induced Sweet syndrome. To date, six cases, including the patient reported here, have been reported in children.

Keywords

Sweet syndrome Drug induced Children 

Abbreviations

SS

Sweet syndrome

c-ANCA

c-type anti-neutrophil cytoplasmic antibody

TPMT

Thiopurine methyltransferase

GCSF

Granulocyte colony-stimulating factor

References

  1. 1.
    Abecassis S, Ingen-Housz-Oro S, Cavelier-Balloy B et al (2004) Particular histological features of a case of Sweet’s syndrome induced by G-CSF. Ann Dermatol Vénéréol 131:369–372CrossRefPubMedGoogle Scholar
  2. 2.
    Aguiar-Bujanda D, Aguiar-Morales J, Bohn-Sarmiento U (2004) Sweet’s syndrome associated with norfloxacin in a prostate cancer patient. QJM 97:55–56CrossRefPubMedGoogle Scholar
  3. 3.
    Ahn SJ, Choi JH, Sung KJ et al (2000) Sweet’s syndrome presenting with lesions resembling eruptive xanthoma. Br J Dermatol 143:449–450CrossRefPubMedGoogle Scholar
  4. 4.
    Al-Saad K, Khanani MF, Naqvi A et al (2004) Sweet syndrome developing during treatment with all-trans retinoic acid in a child with acute myelogenous leukemia. J Pediatr Hematol Oncol 26:197–199CrossRefPubMedGoogle Scholar
  5. 5.
    Alvaro T, Garcia del Moral R, Gomez-Morales M et al (1991) Immunopathological studies of Sweet’s syndrome. Br J Dermatol 124:111–112CrossRefPubMedGoogle Scholar
  6. 6.
    Arbetter KR, Hubbard KW, Markovic SN et al (1999) Case of granulocyte colony-stimulating factor-induced Sweet’s syndrome. Am J Hematol 61:126–129CrossRefPubMedGoogle Scholar
  7. 7.
    Bianchi L, Masi M, Hagman JH et al (1999) Systemic interferon-alpha treatment for idiopathic Sweet’s syndrome. Clin Exp Dermatol 24:443–445CrossRefPubMedGoogle Scholar
  8. 8.
    Bidyasar S, Montoya M, Suleman K et al (2008) Sweet syndrome associated with granulocyte colony-stimulating factor. J Clin Oncol 26:4355–4356CrossRefPubMedGoogle Scholar
  9. 9.
    Boatman BW, Taylor RC, Klein LE et al (1994) Sweet’s syndrome in children. South Med J 87:193–196CrossRefPubMedGoogle Scholar
  10. 10.
    Christ E, Linka A, Jacky E et al (1996) Sweet’s syndrome involoving the musculoskeletal system during treatment of promyelocytic leukemia with all-trans retinoic acid. Leukemia 10:731–734PubMedGoogle Scholar
  11. 11.
    Cobb MW (1989) Furosemide-induced eruption simulating Sweet’s syndrome. J Am Acad Dermatol 21:339–343CrossRefPubMedGoogle Scholar
  12. 12.
    Cohen PR (2007) Sweet’s syndrome—a comprehensive review of an acute febrile neutrophilic dermatosis. Orphanet J Rare Dis 2:34CrossRefPubMedGoogle Scholar
  13. 13.
    Cohen PR, Almeida L, Kurzrock R (1989) Acute febrile neutrophilic dermatosis. Am Fam Physician 39:199–204PubMedGoogle Scholar
  14. 14.
    Cohen PR, Kurzrock R (1993) Sweet’s syndrome and cancer. Clin Dermatol 11:149–157CrossRefPubMedGoogle Scholar
  15. 15.
    Cohen PR, Kurzrock R (2000) Sweet’s syndrome: a neutrophilic dermatosis classically associated with acute onset and fever. Clin Dermatol 18:265–282CrossRefPubMedGoogle Scholar
  16. 16.
    Cohen PR, Kurzrock R (2003) Sweet’s syndrome revisited: a review of disease concepts. Int J Dermatol 42:761–778CrossRefPubMedGoogle Scholar
  17. 17.
    Cohen PR, Talpaz M, Kurzrock R (1988) Malignancy-associated Sweet’s syndrome: review of the world literature. J Clin Oncol 6:1887–1897PubMedGoogle Scholar
  18. 18.
    Corbett M, Schlup M (2001) Azathioprine hypersensitivity mimicking underlying inflammatory bowel disease. Intern Med J 31:366–367CrossRefPubMedGoogle Scholar
  19. 19.
    Cox NH, O’Brien HA (1994) Sweet’s syndrome associated with trans-retinoic acid treatment in acute promyelocytic leukaemia. Clin Exp Dermatol 19:51–52CrossRefPubMedGoogle Scholar
  20. 20.
    de Fonclare AL, Khosrotehrani K, Aractingi S et al (2007) Erythema nodosum-like eruption as a manifestation of azathioprine hypersensitivity in patients with inflammatory bowel disease. Arch Dermatol 143:744–748CrossRefPubMedGoogle Scholar
  21. 21.
    Del Giudice P, Vandenbos F, Perrin C et al (2004) Sweet’s syndrome following abacavir therapy. J Am Acad Dermatol 51:474–475CrossRefPubMedGoogle Scholar
  22. 22.
    Dunn TR, Saperstein HW, Biederman A et al (1992) Sweet syndrome in a neonate with aseptic meningitis. Pediatr Dermatol 9:288–292CrossRefPubMedGoogle Scholar
  23. 23.
    El-Azhary RA (2003) Azathioprine: current status and future considerations. Int J Dermatol 42:335–341CrossRefPubMedGoogle Scholar
  24. 24.
    El-Azhary RA, Brunner KL, Gibson LE (2008) Sweet syndrome as a manifestation of azathioprine hypersensitivity. Mayo Clin Proc 83:1026–1030CrossRefPubMedGoogle Scholar
  25. 25.
    Fett DL, Gibson LE, Su WP (1995) Sweet’s syndrome: systemic signs and symptoms and associated disorders. Mayo Clin Proc 70:234–240CrossRefPubMedGoogle Scholar
  26. 26.
    Fitzgerald RL, McBurney EI, Nesbitt LT Jr (1996) Sweet’s syndrome. Int J Dermatol 35:9–15CrossRefPubMedGoogle Scholar
  27. 27.
    Fye KH, Crowley E, Berger TG et al (2001) Celecoxib-induced Sweet’s syndrome. J Am Acad Dermatol 45:300–302CrossRefPubMedGoogle Scholar
  28. 28.
    Garey KW, Streetman DS, Rainish MC (1998) Azathioprine hypersensitivity reaction in a patient with ulcerative colitis. Ann Pharmacother 32:425–428CrossRefPubMedGoogle Scholar
  29. 29.
    Garty BZ, Levy I, Nitzan M et al (1996) Sweet syndrome associated with G-CSF treatment in a child with glycogen storage disease type Ib. Pediatrics 97:401–403PubMedGoogle Scholar
  30. 30.
    Gilmour E, Chalmers RJ, Rowlands DJ (1995) Drug-induced Sweet’s syndrome (acute febrile neutrophilic dermatosis) associated with hydralazine. Br J Dermatol 133:490–491CrossRefPubMedGoogle Scholar
  31. 31.
    Ginarte M, Garcia Doval I, Toribio J (1997) Sweet’s syndrome: a study of 16 cases. Med Clin (Barc) 109:588–591Google Scholar
  32. 32.
    Going JJ, Going SM, Myskow MW et al (1987) Sweet’s syndrome: histological and immunohistochemical study of 15 cases. J Clin Pathol 40:175–179CrossRefPubMedGoogle Scholar
  33. 33.
    Gray LC, Abele DC (1998) Annular erythematous plaques and tibial pain in a child. Sweet syndrome. Arch Dermatol 134(625–626):628–629Google Scholar
  34. 34.
    Guimera FJ, Garcia-Bustinduy M, Noda A et al (2000) Diazepam-associated Sweet’s syndrome. Int J Dermatol 39:795–798CrossRefPubMedGoogle Scholar
  35. 35.
    Gyorfy A, Kovacs T, Szegedi I et al (2003) Sweet syndrome associated with 13-cis-retinoic acid (isotretinoin) therapy. Med Pediatr Oncol 40:135–136CrossRefPubMedGoogle Scholar
  36. 36.
    Halpern J, Salim A (2009) Pediatric sweet syndrome: case report and literature review. Pediatr Dermatol 26:452–457CrossRefPubMedGoogle Scholar
  37. 37.
    Howard R, Tsuchiya A (1998) Adult skin disease in the pediatric patient. Dermatol Clin 16:593–608CrossRefPubMedGoogle Scholar
  38. 38.
    Itami S, Nishioka K (1980) Sweet’s syndrome in infancy. Br J Dermatol 103:449–451CrossRefPubMedGoogle Scholar
  39. 39.
    Jordaan HF (1989) Acute febrile neutrophilic dermatosis. A histopathological study of 37 patients and a review of the literature. Am J Dermatopathol 11:99–111CrossRefPubMedGoogle Scholar
  40. 40.
    Klock JC, Oken RL (1976) Febrile neutrophilic dermatosis in acute myelogenous leukemia. Cancer 37:922–927CrossRefPubMedGoogle Scholar
  41. 41.
    Knowles S, Shear NH (1997) Azathioprine hypersensitivity reactions: caution upon rechallenge. Muscle Nerve 20:1467–1468CrossRefPubMedGoogle Scholar
  42. 42.
    Kumar G, Bernstein JM, Waibel JS et al (2004) Sweet’s syndrome associated with sargramostim (granulocyte-macrophage colony stimulating factor) treatment. Am J Hematol 76:283–285CrossRefPubMedGoogle Scholar
  43. 43.
    Magro CM, Crowson AN (1997) A distinctive vesiculopustular eruption associated with hepatobiliary disease. Int J Dermatol 36:837–844CrossRefPubMedGoogle Scholar
  44. 44.
    Majeed HA, Kalaawi M, Mohanty D et al (1989) Congenital dyserythropoietic anemia and chronic recurrent multifocal osteomyelitis in three related children and the association with Sweet syndrome in two siblings. J Pediatr 115:730–734CrossRefPubMedGoogle Scholar
  45. 45.
    McGovern DP, Travis SP, Duley J et al (2002) Azathioprine intolerance in patients with IBD may be imidazole-related and is independent of TPMT activity. Gastroenterology 122:838–839CrossRefPubMedGoogle Scholar
  46. 46.
    McLeod HL, Krynetski EY, Relling MV et al (2000) Genetic polymorphism of thiopurine methyltransferase and its clinical relevance for childhood acute lymphoblastic leukemia. Leukemia 14:567–572CrossRefPubMedGoogle Scholar
  47. 47.
    Mensing H, Kowalzick L (1991) Acute febrile neutrophilic dermatosis (Sweet’s syndrome) caused by minocycline. Dermatologica 182:43–46CrossRefPubMedGoogle Scholar
  48. 48.
    Miller RM, Darben TA, Nedwich J et al (1999) Propylthiouracil-induced antineutrophil cytoplasmic antibodies in a patient with Graves’ disease and a neutrophilic dermatosis. Br J Dermatol 141:943–944CrossRefPubMedGoogle Scholar
  49. 49.
    Morgan KW, Callen JP (2001) Sweet’s syndrome in acute myelogenous leukemia presenting as periorbital cellulitis with an infiltrate of leukemic cells. J Am Acad Dermatol 45:590–595CrossRefPubMedGoogle Scholar
  50. 50.
    Noda K, Okuma Y, Fukae J et al (2001) Sweet’s syndrome associated with encephalitis. J Neurol Sci 188:95–97CrossRefPubMedGoogle Scholar
  51. 51.
    Otheo E, Ros P, Vazquez JL et al (2002) Systemic inflammatory response syndrome associated with Sweet’s syndrome. Pediatr Crit Care Med 3:190–193CrossRefPubMedGoogle Scholar
  52. 52.
    Ozdemir D, Korkmaz U, Sahin I et al (2006) Ofloxacin induced Sweet’s syndrome in a patient with Crohn’s disease. J Infect 52:e155–e157CrossRefPubMedGoogle Scholar
  53. 53.
    Paoluzi OA, Crispino P, Amantea A et al (2004) Diffuse febrile dermatosis in a patient with active ulcerative colitis under treatment with steroids and azathioprine: a case of Sweet’s syndrome. Case report and review of literature. Dig Liver Dis 36:361–366CrossRefPubMedGoogle Scholar
  54. 54.
    Parsapour K, Reep MD, Gohar K et al (2003) Familial Sweet’s syndrome in 2 brothers, both seen in the first 2 weeks of life. J Am Acad Dermatol 49:132–138CrossRefPubMedGoogle Scholar
  55. 55.
    Piette WW, Trapp JF, O’Donnell MJ et al (1994) Acute neutrophilic dermatosis with myeloblastic infiltrate in a leukemia patient receiving all-trans-retinoic acid therapy. J Am Acad Dermatol 30:293–297CrossRefPubMedGoogle Scholar
  56. 56.
    Retief CR, Malkinson FD (1999) Nitrofurantoin-associated Sweet’s syndrome. Cutis 63:177–179PubMedGoogle Scholar
  57. 57.
    Sarkany RP, Burrows NP, Grant JW et al (1998) The pustular eruption of ulcerative colitis: a variant of Sweet’s syndrome? Br J Dermatol 138:365–366CrossRefPubMedGoogle Scholar
  58. 58.
    Saxe N, Gordon W (1978) Acute febrile neutrophilic dermatosis (Sweet’s syndrome). Four case reports. S Afr Med J 53:253–256PubMedGoogle Scholar
  59. 59.
    Schonfeldt-Lecuona C, Connemann BJ (2002) Sweet’s syndrome and polyserositis with clozapine. Am J Psychiatry 159:1947CrossRefPubMedGoogle Scholar
  60. 60.
    Shimizu T, Yoshida I, Eguchi H et al (1996) Sweet syndrome in a child with aplastic anemia receiving recombinant granulocyte colony-stimulating factor. J Pediatr Hematol Oncol 18:282–284CrossRefPubMedGoogle Scholar
  61. 61.
    Sinico RA, Sabadini E, Borlandelli S et al (2003) Azathioprine hypersensitivity: report of two cases and review of the literature. J Nephrol 16:272–276PubMedGoogle Scholar
  62. 62.
    Sitjas D, Puig L, Cuatrecasas M et al (1993) Acute febrile neutrophilic dermatosis (Sweet’s syndrome). Int J Dermatol 32:261–268CrossRefPubMedGoogle Scholar
  63. 63.
    Su WP, Liu HN (1986) Diagnostic criteria for Sweet’s syndrome. Cutis 37:167–174PubMedGoogle Scholar
  64. 64.
    Sweet RD (1964) An acute febrile neutrophilic dermatosis. Br J Dermatol 76:349–356CrossRefPubMedGoogle Scholar
  65. 65.
    Tefany FJ, Georgouras K (1991) A neutrophilic reaction of Sweet’s syndrome type associated with the oral contraceptive. Australas J Dermatol 32:55–59CrossRefPubMedGoogle Scholar
  66. 66.
    Thibault MJ, Billick RC, Srolovitz H (1992) Minocycline-induced Sweet’s syndrome. J Am Acad Dermatol 27:801–804CrossRefPubMedGoogle Scholar
  67. 67.
    Thompson DF, Montarella KE (2007) Drug-induced Sweet’s syndrome. Ann Pharmacother 41:802–811CrossRefPubMedGoogle Scholar
  68. 68.
    Thompson MA, Dyson SW, Faderl S (2006) Sweet’s syndrome in chronic lymphocytic leukemia associated with neutropenic fever and granulocyte colony stimulation factor. Am J Hematol 81:703–705CrossRefPubMedGoogle Scholar
  69. 69.
    Tomas JF, Escudero A, Fernandez-Ranada JM (1994) All-trans retinoic acid treatment and Sweet syndrome. Leukemia 8:1596PubMedGoogle Scholar
  70. 70.
    Uhara H, Saida T, Nakazawa H et al (2008) Neutrophilic dermatoses with acute myeloid leukemia associated with an increase of serum colony-stimulating factor. J Am Acad Dermatol 59:S10–S12CrossRefPubMedGoogle Scholar
  71. 71.
    Veres K, Haraszti A, Nemes Z et al (1999) Sweet syndrome following therapeutic use of granulocyte colony stimulating factor. Orv Hetil 140:1059–1061PubMedGoogle Scholar
  72. 72.
    von den Driesch P (1994) Sweet’s syndrome (acute febrile neutrophilic dermatosis). J Am Acad Dermatol 31:535–556, quiz 557–560CrossRefPubMedGoogle Scholar
  73. 73.
    Walker DC, Cohen PR (1996) Trimethoprim-sulfamethoxazole-associated acute febrile neutrophilic dermatosis: case report and review of drug-induced Sweet’s syndrome. J Am Acad Dermatol 34:918–923CrossRefPubMedGoogle Scholar
  74. 74.
    White JM, Mufti GJ, Salisbury JR et al (2006) Cutaneous manifestations of granulocyte colony-stimulating factor. Clin Exp Dermatol 31:206–207CrossRefPubMedGoogle Scholar
  75. 75.
    Yiasemides E, Thom G (2009) Azathioprine hypersensitivity presenting as a neutrophilic dermatosis in a man with ulcerative colitis. Australas J Dermatol 50:48–51CrossRefPubMedGoogle Scholar
  76. 76.
    Ytting H, Vind I, Bang D et al (2005) Sweet’s syndrome-an extraintestinal manifestation in inflammatory bowel disease. Digestion 72:195–200CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  1. 1.Department of PediatricsSamsung Medical Center, Sungkyunkwan University School of MedicineSeoulSouth Korea

Personalised recommendations